Form 4 for INDV Indivior Pharmaceuticals, Inc.
Accepted 2026-03-05 00:00:00 ET · period of report 2026-03-03 · accession 0002014639-26-000006 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-03-05 | 2026-03-03 | INDV | Heidbreder Christian | CSO | M - OptEx | — | +101.5K | 292.3K | +53% | — |
| D | 2026-03-05 | 2026-03-03 | INDV | Heidbreder Christian | CSO | F - Tax | $31.98 | -45.8K | 246.5K | -16% | -$1.46M |
| D | 2026-03-05 | 2026-03-03 | INDV | Heidbreder Christian | CSO | M - OptEx | — | -132.6K | 0 | -100% | — |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-03-03 | M | A | 101,544 | — | 292,306 | D | — | — | (F1) Represents the vesting of performance stock units upon the determination that the performance conditions were met at 76.6% with respect to the performance stock units granted to the Reporting Person on March 3, 2023, of which 101,544 shares vested out of the 132,565 target amount. (F2) Each performance stock unit represents a contingent right to receive one share of the Issuer's common stock. |
| 2 | Common | Common Stock | 2026-03-03 | F | D | 45,797 | $31.98 | 246,509 | D | — | — | (F3) Shares used to satisfy tax withholding obligations associated with the vesting of performance stock units on March 3, 2026. |
| 3 | Derivative | Performance Stock Units | 2026-03-03 | M | D | 132,565 | — | 0 | D | $0.00 · 2026-03-03 to — | 132,565 Common Stock | (F2) Each performance stock unit represents a contingent right to receive one share of the Issuer's common stock. (F1) Represents the vesting of performance stock units upon the determination that the performance conditions were met at 76.6% with respect to the performance stock units granted to the Reporting Person on March 3, 2023, of which 101,544 shares vested out of the 132,565 target amount. |